
Omidenepag: A New Category of Topical Glaucoma Therapy
Drs. Amanda Bicket and Lori Provencher join Dr. Andrew Pouw to discuss omidenepag isopropyl (Omlonti), the recently FDA-approved eye drop for treating elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.
For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.